Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB-WT) Gross Profit (2024 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Gross Profit for 2 consecutive years, with $49.0 million as the latest value for Q4 2025.

  • Quarterly Gross Profit rose 3179.46% to $49.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $62.0 million through Dec 2025, up 7704.53% year-over-year, with the annual reading at $62.0 million for FY2025, 7704.53% up from the prior year.
  • Gross Profit for Q4 2025 was $49.0 million at Nuvation Bio, up from $9.8 million in the prior quarter.
  • The five-year high for Gross Profit was $49.0 million in Q4 2025, with the low at -$788000.0 in Q3 2024.